Champions Oncology, Inc. (CSBR)
4.94
+0.06
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
5.17
+0.23
(+4.66%)
After-Hours: 20:00
Champions Oncology Price : 4.94 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 5.04 | 5.066 | 4.92 | 4.94 | 3555.00 |
| Oct 01, 2026 | 4.97 | 5.04 | 4.86 | 4.88 | 2421.00 |
| Sep 30, 2026 | 4.86 | 5.00 | 4.80 | 5.00 | 35206.00 |
| Sep 29, 2026 | 4.97 | 5.04 | 4.79 | 4.79 | 15116.00 |
| Sep 28, 2026 | 4.90 | 4.98 | 4.89 | 4.93 | 4355.00 |
| Sep 25, 2026 | 4.81 | 4.955 | 4.800 | 4.90 | 8796.00 |
| Sep 24, 2026 | 4.942 | 4.95 | 4.942 | 4.95 | 3707.00 |
| Sep 23, 2026 | 5.10 | 5.31 | 5.02 | 5.02 | 1501.00 |
| Sep 22, 2026 | 4.94 | 5.29 | 4.94 | 5.29 | 11309.00 |
| Sep 21, 2026 | 5.30 | 5.30 | 5.077 | 5.26 | 10391.00 |
| Sep 18, 2026 | 5.09 | 5.64 | 4.94 | 5.30 | 28871.00 |
| Sep 17, 2026 | 4.99 | 5.20 | 4.87 | 5.08 | 28880.00 |
| Sep 16, 2026 | 4.75 | 5.12 | 4.59 | 4.95 | 31706.00 |
| Sep 15, 2026 | 4.855 | 5.059 | 4.64 | 4.77 | 30184.00 |
| Sep 14, 2026 | 5.00 | 5.01 | 4.92 | 4.92 | 1796.00 |
| Sep 11, 2026 | 5.17 | 5.23 | 5.00 | 5.10 | 10113.00 |
| Sep 10, 2026 | 5.19 | 5.269 | 5.05 | 5.096 | 14576.00 |
| Sep 09, 2026 | 4.95 | 5.15 | 4.85 | 5.01 | 28804.00 |
| Sep 08, 2026 | 5.11 | 5.21 | 5.05 | 5.05 | 15288.00 |
| Sep 04, 2026 | 5.282 | 5.41 | 5.06 | 5.22 | 10947.00 |
| Sep 03, 2026 | 5.279 | 5.51 | 5.16 | 5.28 | 11813.00 |
| Sep 02, 2026 | 5.150 | 5.240 | 5.00 | 5.15 | 9240.00 |
| Sep 01, 2026 | 5.06 | 5.06 | 5.00 | 5.00 | 2049.00 |
| Aug 31, 2026 | 5.015 | 5.021 | 4.97 | 4.995 | 744.00 |
| Aug 28, 2026 | 5.10 | 5.10 | 4.93 | 4.93 | 5142.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Medpace Holdings, Inc. | 599.47 |
| Avantor, Inc. | 15.34 |
| Personalis, Inc. | 16.28 |
| Adaptive Biotechnologies Corp. | 28.35 |
| 10X Genomics, Inc. | 93.50 |
Price Related Metrics
| PS Ratio | 1.143 |
| Price to Book Value | 17.66 |
| Earnings Yield | -1.62% |
| Market Cap | 68.76M |